↓ Skip to main content

Dove Medical Press

Article Metrics

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, October 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Readers on

mendeley
21 Mendeley
Title
Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
Published in
ClinicoEconomics and Outcomes Research: CEOR, October 2013
DOI 10.2147/ceor.s43087
Pubmed ID
Authors

S Walzer, K Travers, S Rieder, E Erazo-Fischer, D Matusiewicz

Abstract

In Europe a disease is recognized as rare if less than 1 in 2000 people suffer from the specific disease. In patients with familial homozygous hypercholesterolemia (HoFH) the accumulation of low-density lipoprotein cholesterol (LDL-C) leads to generalized atherosclerosis due to an insufficient functioning of the LDL-C receptors. Patients die early sometimes even in the mid-30s, from myocardial infarction or stroke. For the German population, insufficient epidemiological evidence exists.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 24%
Student > Postgraduate 3 14%
Student > Doctoral Student 3 14%
Other 2 10%
Student > Bachelor 2 10%
Other 3 14%
Unknown 3 14%
Readers by discipline Count As %
Medicine and Dentistry 8 38%
Agricultural and Biological Sciences 5 24%
Biochemistry, Genetics and Molecular Biology 2 10%
Environmental Science 1 5%
Engineering 1 5%
Other 0 0%
Unknown 4 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2014.
All research outputs
#2,179,478
of 3,900,959 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#91
of 132 outputs
Outputs of similar age
#51,241
of 98,189 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#14
of 14 outputs
Altmetric has tracked 3,900,959 research outputs across all sources so far. This one is in the 25th percentile – i.e., 25% of other outputs scored the same or lower than it.
So far Altmetric has tracked 132 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,189 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.